PHS
PTCT icon

PFM Health Sciences’s PTC Therapeutics PTCT Stock Holding History

PFM Health Sciences’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,654,225
Closed -$55.9M – 73
2019
Q3 		$55.9M Buy
+1,654,225
New +$72M 1.65% 21
2019
Q2 		– Sell
-1,086,776
Closed -$40.9M – 97
2019
Q1 		$40.9M Buy
+1,086,776
New +$36.5M 0.9% 37
2015
Q3 		– Sell
-116,268
Closed -$4.97M – 96
2015
Q2 		$5.6M Buy
116,268
+64,939
+127% +$3.79M 0.14% 73
2015
Q1 		$3.12M Sell
51,329
-79,770
-61% -$4.87M 0.09% 79
2014
Q4 		$6.79M Buy
+131,099
New +$5.77M 0.16% 80

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PFM Health Sciences's PTCT Position: Q4 2019 in Review

PFM Health Sciences sold out of PTC Therapeutics (PTCT) in Q4 2019, closing a stake of 1,654,225 shares — an estimated $55.9M sold.

PFM Health Sciences first reported a position in PTCT in Q4 2014 and held it in 5 quarters. The position peaked at $55.9M in Q3 2019. 206 funds tracked by Wall St. Rank hold PTCT as of Q4 2019.

  • PFM Health Sciences reported no remaining PTC Therapeutics position as of Q4 2019 after selling out during the quarter.
  • PFM Health Sciences sold 1,654,225 PTC Therapeutics shares in Q4 2019, an estimated $55.9M.
  • PFM Health Sciences first reported a position in PTC Therapeutics in Q4 2014 and held it in 5 quarters.
  • PFM Health Sciences's PTC Therapeutics position peaked at $55.9M in Q3 2019.
  • 206 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2019.

Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.